The gut-liver axis in immune remodeling of hepatic cirrhosis

被引:15
作者
Guan, Huayu [1 ,2 ]
Zhang, Xiang [1 ]
Kuang, Ming [2 ]
Yu, Jun [1 ]
机构
[1] Chinese Univ Hong Kong, Inst Digest Dis, Dept Med & Therapeut, State Key Lab Digest Dis, Hong Kong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Hepatopancreatobiliary Surg, Dept Liver Surg, Guangzhou, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
关键词
gut-liver axis; microbiota; immune; gut microbiome; liver cirrhosis; immune homeostasis; immune remodeling; INTESTINAL BACTERIAL OVERGROWTH; UNFOLDED PROTEIN RESPONSE; VASCULAR BARRIER; CELL-FUNCTION; T-CELLS; INFLAMMATION; TRANSLOCATION; MICROBIOME; INFECTION; FIBROSIS;
D O I
10.3389/fimmu.2022.946628
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In healthy settings, the gut-liver axis allows host-microbiota communications and mediates immune homeostasis through bidirectional regulation. Meanwhile, in diseases, gut dysbiosis, combined with an impaired intestinal barrier, introduces pathogens and their toxic metabolites into the system, causing massive immune alternations in the liver and other extrahepatic organs. Accumulating evidence suggests that these immune changes are associated with the progression of many liver diseases, especially hepatic cirrhosis. Pathogen-associated molecular patterns that originated from gut microbes directly stimulate hepatocytes and liver immune cells through different pattern recognition receptors, a process further facilitated by damage-associated molecular patterns released from injured hepatocytes. Hepatic stellate cells, along with other immune cells, contribute to this proinflammatory and profibrogenic transformation. Moreover, cirrhosis-associated immune dysfunction, an imbalanced immune status characterized by systemic inflammation and immune deficiency, is linked to gut dysbiosis. Though the systemic inflammation hypothesis starts to link gut dysbiosis to decompensated cirrhosis from a clinical perspective, a clearer demonstration is still needed for the role of the gut-liver-immune axis in cirrhosis progression. This review discusses the different immune states of the gut-liver axis in both healthy and cirrhotic settings and, more importantly, summarizes the current evidence about how microbiota-derived immune remodeling contributes to the progression of hepatic cirrhosis via the gut-liver axis.
引用
收藏
页数:13
相关论文
共 116 条
  • [1] Cirrhosis-associated immune dysfunction
    Albillos, Agustin
    Martin-Mateos, Rosa
    van der Merwe, Schalk
    Wiest, Reiner
    Jalan, Rajiv
    Alvarez-Mon, Melchor
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2022, 19 (02) : 112 - 134
  • [2] The gut-liver axis in liver disease: Pathophysiological basis for therapy
    Albillos, Agustin
    de Gottardi, Andrea
    Rescigno, Maria
    [J]. JOURNAL OF HEPATOLOGY, 2020, 72 (03) : 558 - 577
  • [3] Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis
    An, Ping
    Wei, Lin-Lin
    Zhao, Shuangshuang
    Sverdlov, Deanna Y.
    Vaid, Kahini A.
    Miyamoto, Makoto
    Kuramitsu, Kaori
    Lai, Michelle
    Popov, Yury, V
    [J]. NATURE COMMUNICATIONS, 2020, 11 (01)
  • [4] Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
    Aron-Wisnewsky, Judith
    Vigliotti, Chloe
    Witjes, Julia
    Le, Phuong
    Holleboom, Adriaan G.
    Verheij, Joanne
    Nieuwdorp, Max
    Clement, Karine
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2020, 17 (05) : 279 - 297
  • [5] The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis
    Arroyo, Vicente
    Angeli, Paolo
    Moreau, Richard
    Jalan, Rajiv
    Claria, Joan
    Trebicka, Jonel
    Fernandez, Javier
    Gustot, Thierry
    Caraceni, Paolo
    Bernardi, Mauro
    [J]. JOURNAL OF HEPATOLOGY, 2021, 74 (03) : 670 - 685
  • [6] Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability
    Assimakopoulos, Stelios F.
    Tsamandas, Athanassios C.
    Tsiaoussis, Georgios I.
    Karatza, Elli
    Triantos, Christos
    Vagianos, Constantine E.
    Spiliopoulou, Iris
    Kaltezioti, Valeria
    Charonis, Aristidis
    Nikolopoulou, Vassiliki N.
    Scopa, Chrisoula D.
    Thomopoulos, Konstantinos C.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (04) : 439 - 446
  • [7] Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells
    Atarashi, Koji
    Tanoue, Takeshi
    Ando, Minoru
    Kamada, Nobuhiko
    Nagano, Yuji
    Narushima, Seiko
    Suda, Wataru
    Imaoka, Akemi
    Setoyama, Hiromi
    Nagamori, Takashi
    Ishikawa, Eiji
    Shima, Tatsuichiro
    Hara, Taeko
    Kado, Shoichi
    Jinnohara, Toshi
    Ohno, Hiroshi
    Kondo, Takashi
    Toyooka, Kiminori
    Watanabe, Eiichiro
    Yokoyama, Shin-ichiro
    Tokoro, Shunji
    Mori, Hiroshi
    Noguchi, Yurika
    Morita, Hidetoshi
    Ivanov, Ivaylo I.
    Sugiyama, Tsuyoshi
    Nunez, Gabriel
    Camp, J. Gray
    Hattori, Masahira
    Umesaki, Yoshinori
    Honda, Kenya
    [J]. CELL, 2015, 163 (02) : 367 - 380
  • [8] The Evolving Challenge of Infections in Cirrhosis
    Bajaj, Jasmohan S.
    Kamath, Patrick S.
    Reddy, K. Rajender
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (24) : 2317 - 2330
  • [9] Bajaj JS, 2020, J HEPATOL, V72, P1003, DOI 10.1016/j.jhep.2020.01.017
  • [10] Long-term Outcomes of Fecal Microbiota Transplantation in Patients With Cirrhosis
    Bajaj, Jasmohan S.
    Fagan, Andrew
    Gavis, Edith A.
    Kassam, Zain
    Sikaroodi, Masoumeh
    Gillevet, Patrick M.
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : 1921 - +